Zomedica Expands Grovet Partnership to Enhance European Reach

Zomedica Corp., a leader in animal health solutions, has broadened its distribution agreement with Grovet b.v., enhancing its presence in the European veterinary market. This expansion introduces Zomedica’s VETIGEL® hemostatic gel, EquiLoop® therapeutic devices, and the TRUFORMA® diagnostic platform to Grovet’s offerings, targeting both equine and companion animals across Europe.

The enhanced agreement enables Zomedica to leverage Grovet’s established distribution network, facilitating entry into the European market by expanding the suite of innovative diagnostic and therapeutic products. This strategic move is anticipated to drive growth in the multi-billion-dollar global veterinary diagnostics and therapeutic equipment sectors.

With Grovet's expertise, Zomedica aims to accelerate the adoption of its technologies, expand revenue opportunities, and strengthen its position in animal health. The global veterinary diagnostics market is forecast to experience significant growth, further supporting Zomedica's expansion strategy.